| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/31/2003 | US20030143661 Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 07/31/2003 | US20030143654 Which participates in the ubiquitin-dependent proteolytic pathway that targets regulatory proteins for rapid intracellular degradation |
| 07/31/2003 | US20030143646 Determining cell proliferation by detecting preinitiation complex (MCM2) of DNA replication without antigen retrieval or pressure cooking/autoclaving; cervical smears |
| 07/31/2003 | US20030143643 Hybrids for testing red blood cells for presence of one or more Rh factors; one-step agglutination |
| 07/31/2003 | US20030143642 Secretions of proteins by encapsulated cells |
| 07/31/2003 | US20030143623 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/31/2003 | US20030143622 Human RNA binding proteins |
| 07/31/2003 | US20030143621 Contacting a cellular component with a reagent which binds to PC-1 (prostate cancer-1) protein |
| 07/31/2003 | US20030143611 Cloning the DNA sequence encoding recombinant SRTA-70 proteins |
| 07/31/2003 | US20030143595 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143576 Method and device for integrated protein expression, purification and detection |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143245 Multivalent streptococcal vaccine compositions and methods for use |
| 07/31/2003 | US20030143241 For inhibiting hepatitis E virus (HEV) infection |
| 07/31/2003 | US20030143234 For therapy of microbial organism infection |
| 07/31/2003 | US20030143226 For therapy of arteriosclerosis, thrombocytopenia, kidneyd iseases, various types of inflammation such as myocardial ischemic reperfusion injury, inflammatory reactions after percutaneous transluminal coronary recanalization (PTCR)) |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143198 Method for preparing a physiologically active il-18 polypeptide |
| 07/31/2003 | US20030143192 Chemokine beta-7 |
| 07/31/2003 | US20030143156 Prevents non- specific binding of the catalytic species to the support; high catalytic activity and permits easy separation and recovery of the catalytic species for reuse |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2510751A1 Multimers of receptor-binding ligands |
| 07/31/2003 | CA2476773A1 Monoclonal antibodies against extracellular loops of c5ar |
| 07/31/2003 | CA2474259A1 Antibodies against and compositions containing new amphetamine derivatives |
| 07/31/2003 | CA2473707A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | CA2473555A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |
| 07/30/2003 | EP1331273A1 Method for producing protein hydrolysate |
| 07/30/2003 | EP1331269A1 Novel protein, process for producing the same and use thereof |
| 07/30/2003 | EP1331266A1 Cells producing antibody compositions |
| 07/30/2003 | EP1331265A2 density enhanced protein tyrosine phosphatases |
| 07/30/2003 | EP1330522A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330521A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/30/2003 | EP1330475A2 Neuromedin u delta polypeptides |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330263A2 Method for down-regulating ige |
| 07/30/2003 | EP0941349B1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
| 07/30/2003 | EP0837694B1 Leptospira membrane proteins |
| 07/30/2003 | EP0730652B1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter |
| 07/30/2003 | CN1433474A Regulaed antigen delivery system (RADS) involving bacteria |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433430A Hepatitis virus sentinel virus I (SVI) |
| 07/30/2003 | CN1116304C Organic compound |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600027 Polynucleotide molecules encoding neospora proteins |
| 07/29/2003 | US6600021 Enzyme inhibitor for use in the preparation of dough and baked goods |
| 07/29/2003 | US6600013 Moraxella catarrhalis BASB034 polypeptides and uses thereof |
| 07/29/2003 | US6599880 Analog further comprises an amino acid substitution; for treating gram-negative bacterial infections in a subject |
| 07/29/2003 | US6599744 Expression vector for use as tool in the transfer nucleotide sequences and generation of heterologous proteins in cells |
| 07/29/2003 | US6599735 Apparatus for use in the culturing of cells and generation of heterologous proteins |
| 07/29/2003 | US6599727 Human poly (ADP-ribose) polymerase 2 materials and methods |
| 07/29/2003 | US6599724 Pharmaceutical composition for use in the treatment of blood disorders |
| 07/29/2003 | US6599723 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
| 07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
| 07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 07/29/2003 | US6599695 Method for assaying for early gene expression in neuroblasts |
| 07/29/2003 | US6599508 Truncated papillomavirus L1 protein, vaccine |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2189971C Vaccine for moraxella catarrhalis |
| 07/29/2003 | CA2133838C Immunotoxins directed against cd33 related surface antigens |
| 07/29/2003 | CA2122044C Hiv immunotherapeutics |
| 07/29/2003 | CA2082802C Method for expressing polypeptides in cyanobacteria |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/29/2003 | CA2067136C Growth hormone antagonists |
| 07/25/2003 | CA2425623A1 Promoter promoting expression of a foreign gene in root and shoot apex |
| 07/24/2003 | WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | WO2003060143A2 Efficient protein expression system |
| 07/24/2003 | WO2003060141A1 Manufacturing method of recombinant protein in yeast by the use of secretory type vector |
| 07/24/2003 | WO2003060118A1 Iron-sulfur protein, protein-fad complex, electron transporter and method of measuring the inhibition of ferredotoxin activity |
| 07/24/2003 | WO2003060093A2 METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060084A2 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 07/24/2003 | WO2003060072A2 Recombinant polypeptides |
| 07/24/2003 | WO2003060071A2 Albumin fusion proteins |
| 07/24/2003 | WO2003060068A2 Oxa1p enhanced protein secretion |
| 07/24/2003 | WO2003060065A2 Adapter-directed display system |
| 07/24/2003 | WO2003059953A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059945A2 Soluble recombinant protein production |
| 07/24/2003 | WO2003059941A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 07/24/2003 | WO2003059935A2 Methods for purifying protein |
| 07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
| 07/24/2003 | WO2003059385A2 Hiv vaccine and method of use |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059272A2 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003029291A3 Pegylated and diglycosylated erythropoietin |
| 07/24/2003 | WO2003020924A3 Stable storage of proteins |
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof |